|
Health Economics
Citations 11-20 of 98 total displayed.
|
Past content
(since Jan 2001):
|
- MATTERS ARISING
Rheumatology nurse specialists—do we need them?
- S. M. Oliver
Rheumatology 2007; 46: 1380-1381.
[Extract]
[Full Text]
- CLINICAL
The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis
- E. C. F. Wilson, D. R. W. Jayne, E. Dellow, and R. J. Fordham
Rheumatology 2007; 46: 1096-1101.
[Abstract]
[Full Text]
[ Supplementary Data ]
- CLINICAL
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis
- C. A. E. Walsh, P. Minnock, C. Slattery, N. Kennedy, F. Pang, D. J. Veale, B. Bresnihan, and O. FitzGerald
Rheumatology 2007; 46: 1148-1152.
[Abstract]
[Full Text]
- GUIDELINES
Provisional guidelines for applying the Department of Health (England) 18-week-patient pathway to specialist rheumatology care
- D. A. Walsh, C. Kelly, A. Bosworth, C. Price, and G. Burbage
Rheumatology 2007; 46: 1200-1206.
[Abstract]
[Full Text]
- EDITORIALS
Anti-tumour necrosis factor therapy for ankylosing spondylitis—unresolved issues
- R. N. Jois, K. Gaffney, and A. Keat
Rheumatology 2007; 46: 899-901.
[Extract]
[Full Text]
- CLINICAL
Trends in economic consequences of rheumatoid arthritis over two subsequent years
- S. M. M. Verstappen, J. W. G. Jacobs, A. A. Kruize, J. C. Ehrlich, G. A. van Albada-Kuipers, H. Verkleij, E. Buskens, and J. W. J. Bijlsma
Rheumatology 2007; 46: 968-974.
[Abstract]
[Full Text]
- MATTERS ARISING
The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis
- N. Smith, K. Gadsby, S. Butt, and C. Deighton
Rheumatology 2007; 46: 1044-1045.
[Extract]
[Full Text]
- CLINICAL
The challenges of integrating ultrasonography into routine rheumatology practice: addressing the needs of clinical rheumatologists
- A. K. Brown, T. E. Roberts, R. J. Wakefield, Z. Karim, E. Hensor, P. J. O'Connor, and P. Emery
Rheumatology 2007; 46: 821-829.
[Abstract]
[Full Text]
- CLINICAL
A cost analysis of Behçet's syndrome in Turkey
- N. Sut, E. Seyahi, S. Yurdakul, M. Senocak, and H. Yazici
Rheumatology 2007; 46: 678-682.
[Abstract]
[Full Text]
- EDITORIALS
What is a rheumatologist for?
- Josh Dixey, (Hon Secre and Andrew Bamji, (President
Rheumatology 2007; 46: 377-378.
[Extract]
[Full Text]
|
|
